Clinical trial
MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
NCT02006069 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2013
- Completion date
- May 30, 2021
- Enrollment
- 5,850 (actual)
- Sites
- 206
Conditions
As the registry lists them; a condition with its own page is linked.